FDA to Continue to Refuse Imports from Jamaican Drug Company
The Food and Drug Administration sent a warning letter to P.A. Benjamin Manufacturing, a drug company based in Jamaica, detailing violations of current good manufacturing practice regulations, as well as unapproved new drug and misbranding violations. Specific problems included labeling…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
violations and use of active ingredients that do not comply with requirements for cold and cough medicines for over-the-counter use. FDA said it may continue to refuse admission of drugs manufactured at P.A. Benjamin’s Kingston facility as a result.